Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Advancis grosses $27.25mm from private financing

Executive Summary

Advancis Pharmaceutical (develops anti-infectives) grossed $27.25mm through the private placement of 6.8mm common shares priced at $3.98 each, a slight discount to the market average. Returning shareholders Omega Fund, HealthCare Ventures, Rho Ventures, and new institutional investors (who bought about 1mm shares) participated.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies